Skip to main content

Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial

  • Ruisong Pei (a1) (a2), Diana M. DiMarco (a1), Kelley K. Putt (a2), Derek A. Martin (a1) (a2), Qinlei Gu (a2), Chureeporn Chitchumroonchokchai (a3), Heather M. White (a4), Cameron O. Scarlett (a5), Richard S. Bruno (a3) and Bradley W. Bolling (a1) (a2)...

The anti-inflammatory mechanisms of low-fat dairy product consumption are largely unknown. The objective of this study was to determine whether low-fat yogurt reduces biomarkers of chronic inflammation and endotoxin exposure in women. Premenopausal women (BMI 18·5–27 and 30–40 kg/m2) were randomised to consume 339 g of low-fat yogurt (yogurt non-obese (YN); yogurt obese (YO)) or 324 g of soya pudding (control non-obese; control obese (CO)) daily for 9 weeks (n 30/group). Fasting blood samples were analysed for IL-6, TNF-α/soluble TNF II (sTNF-RII), high-sensitivity C-reactive protein, 2-arachidonoyl glycerol, anandamide, monocyte gene expression, soluble CD14 (sCD14), lipopolysaccharide (LPS), LPS binding protein (LBP), IgM endotoxin-core antibody (IgM EndoCAb), and zonulin. BMI, waist circumference and blood pressure were also determined. After 9-week yogurt consumption, YO and YN had decreased TNF-α/sTNFR-RII. Yogurt consumption increased plasma IgM EndoCAb regardless of obesity status. sCD14 was not affected by diet, but LBP/sCD14 was lowered by yogurt consumption in both YN and YO. Yogurt intervention increased plasma 2-arachidonoylglycerol in YO but not YN. YO peripheral blood mononuclear cells expression of NF-κB inhibitor α and transforming growth factor β1 increased relative to CO at 9 weeks. Other biomarkers were unchanged by diet. CO and YO gained approximately 0·9 kg in body weight. YO had 3·6 % lower diastolic blood pressure at week 3. Low-fat yogurt for 9 weeks reduced biomarkers of chronic inflammation and endotoxin exposure in premenopausal women compared with a non-dairy control food. This trial was registered as NCT01686204.

Corresponding author
* Corresponding author: B. W. Bolling, fax +1 608 262 6872, email
Hide All
1. Lumeng, CN & Saltiel, AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121, 21112117.
2. Gregor, MF & Hotamisligil, GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415445.
3. Sun, L, Yu, Z, Ye, X, et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33, 19251932.
4. Cani, PD, Plovier, H, Van Hul, M, et al. (2016) Endocannabinoids - at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 12, 133143.
5. Andreasen, AS, Larsen, N, Pedersen-Skovsgaard, T, et al. (2010) Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104, 18311838.
6. Pei, R, Martin, DA, DiMarco, DM, et al. (2017) Evidence for the effects of yogurt on gut health and obesity. Crit Rev Food Sci Nutr 57, 15691583.
7. Schiffrin, EJ, Parlesak, A, Bode, C, et al. (2009) Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. Br J Nutr 101, 961966.
8. Zeng, J, Li, YQ, Zuo, XL, et al. (2008) Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 28, 9941002.
9. Matsumoto, M, Ohishi, H & Benno, Y (2001) Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol 31, 181186.
10. Yang, YJ & Sheu, BS (2012) Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter 17, 297304.
11. Warensjö, E, Jansson, JH, Cederholm, T, et al. (2010) Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case--control study. Am J Clin Nutr 92, 194202.
12. Tong, X, Dong, JY, Wu, ZW, et al. (2011) Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr 65, 10271031.
13. Ralston, RA, Lee, JH, Truby, H, et al. (2012) A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J Hum Hypertens 26, 313.
14. Laugerette, F, Vors, C, Géloën, A, et al. (2011) Emulsified lipids increase endotoxemia: Possible role in early postprandial low-grade inflammation. J Nutr Biochem 22, 5359.
15. Campbell, MJ & Swinscow, TDV (2009) Statistics at Square One, 11th ed. West Sussex: Wiley-Blackwell, Inc.
16. Pickering, TG, Hall, JE, Appel, LJ, et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 45, 142161.
17. Thompson, FE & Subar, AF (2017) Dietary Assessment Methodology. In Nutrition in the Prevention and Treatment of Disease, 4th ed., pp. 548 [AM Coulston, CJ Boushey, MG Ferruzzi and LM Delahanty, editors]. London: Academic Press.
18. Laugerette, F, Furet, JP, Debard, C, et al. (2012) Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am J Physiol Endocrinol Metab 302, 374386.
19. Laugerette, F, Alligier, M, Bastard, JP, et al. (2014) Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol Nutr Food Res 58, 15131518.
20. Panagiotakos, DB, Pitsavos, C, Yannakoulia, M, et al. (2005) The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 183, 308315.
21. Mauras, N, DelGiorno, C, Kollman, C, et al. (2010) Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 95, 10601068.
22. Manco, M, Putignani, L & Bottazzo, GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31, 817844.
23. Scherer, DC, Brockman, JA, Chen, ZJ, et al. (1995) Signal-induced degradation of I-kappa-B-alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A 92, 1125911263.
24. Serhan, CN & Savill, J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6, 11911197.
25. Kallio, KAE, Hatonen, KA, Lehto, M, et al. (2015) Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetol 52, 395404.
26. Gnauck, A, Lentle, RG & Kruger, MC (2015) The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects. J Immunol Methods 416, 146156.
27. Pais de Barros, J-P, Gautier, T, Sali, W, et al. (2015) Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay. J Lipid Res 56, 13631369.
28. Schroder, NWJ & Schumann, RR (2005) Non-LPS targets and actions of LPS binding protein (LBP). J Endotoxin Res 11, 237242.
29. Gonzalez-Quintela, A, Alonso, M, Campos, J, et al. (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLOS ONE 8, e54600.
30. Poxton, IR (1995) Antibodies to lipopolysaccharide. J Immunol Methods 186, 115.
31. Hawkesworth, S, Moore, SE, Fulford, AJ, et al. (2013) Evidence for metabolic endotoxemia in obese and diabetic Gambian women. Nutr Diabetes 3, e83.
32. Putt, K, Pei, R, White, W, et al. (2017) Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions. Food Funct 8, 406414.
33. Morenga, LT, Mallard, S & Mann, J (2012) Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 345, e7492.
34. Soedamah-Muthu, SS, Verberne, LDM, Ding, EL, et al. (2012) Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension 60, 11311137.
35. Bordoni, A, Danesi, F, Dardevet, D, et al. (2017) Dairy products and inflammation: a review of the clinical evidence. Crit Rev Food Sci Nutr 57, 24972525.
36. Boudry, G, Hamilton, MK, Chichlowski, M, et al. (2017) Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice. J Dairy Sci 100, 2471–248.
37. Anderson, RC, Bassett, SA, Haggarty, NW, et al. (2017) Short communication: early-lactation, but not mid-lactation, bovine lactoferrin preparation increases epithelial barrier integrity of Caco-2 cell layers. J Dairy Sci 100, 886891.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Pei et al. supplementary material
Pei et al. supplementary material 1

 Word (42 KB)
42 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed